With modern validated methods, we enable the future of care - from home or in the clinic. This improves patient access, frees up time for health care professionals and provides a more comprehensive and reliable assessment.
The digital tool includes cognitive screening tests performed by the patient at the clinic or home. The test is a further development of traditional paper-and-pen tests (MoCA, MMSE, and clock-test). The tool collects a large amount of data on how the test is conducted and provides cut-off scores to distinguish subjective cognitive impairment, mild cognitive impairment, and suspected cognitive disease/dementia. The test has, in the clinical study, demonstrated higher sensitivity and specificity than other established methods. The time required for tests is also recorded and contributes with additional decision-making documents with limits based on the same clinical study. Every patient is assessed on; memory, visuospatial ability, executive functions, attention/working memory, language, and orientation.
Read more about clinical evidence here.
Complete anamnesis with the tool, carried it out, either by the patient himself with the support of a relative, or by healthcare professional. Health professionals determine cross-cutting areas and intelligent question batteries ask supplementary questions. The anamnesis covers: general information about the patient, perceived cognitive symptoms based on each domain, general health status, heredity, medication, mental health, stress, attention span, addiction, risk factors, and lifestyle/habits.
Relatives can easily contribute with their views on symptom development via the digital version of the neurocognitive symptom questionnaire (CIMP-QUEST). By answering the questions in this well-established framework, a summary generates automatically as an additional basis for decision-making. Ensure consistency by involving relatives and compare the patient's observations to the relatives'. The healthcare interface also provides a reference library with profiles for various cognitive disorders and easily compares them to the patient's profile.
Healthcare professionals can choose which parts of the assessment the patient and relatives should perform. Once these are complete, the results are instantly compiled in the clinical assessment tool for evaluation. Upon patient revisits, compare results without hassle to get a clear picture of progress.
The FINGER study has revolutionized the approach to brain health. It shows the possibilities of reducing the risk of cognitive impairment by changing lifestyle factors in different risk groups. Via the app " Minnesmottagningen " the patient and relatives have access to a risk reduction tool based on parts of the FINGER study. Here you will find information and support to follow habits related to diet, exercise, social interaction and activities to train the brain.
Geras Solutions provides a CE-marked medical device tool class I, according to MDD (Class IIa according to MDR). We work in a structured manner with quality according to ISO13485. Proper management of patient data is also an important part for us and the healthcare providers who use Geras Solutions tools.
Read more about clinical evidence here.
